While expansive versions of a “Green New Deal” have grabbed attention on the left and denial that climate change is human-caused remains a major obstacle on the right, a centrist, bipartisan legislative coalition is emerging on climate and energy policy. It’s time to get things done.
Publications
January 16, 2019
If countries do not show proper restraint, they can easily sabotage the global Internet by imposing unreasonable obligations on companies and setting up scenarios where companies are forced into a no-win situation of having to comply with conflicting laws.
January 15, 2019
In a review for the New York Journal of Books, Rob Atkinson writes that anyone involved in managing any organization, large or small, is likely to find much to appreciate in “Creative Construction: The DNA of Sustained Innovation” by Gary P. Pisano.
January 15, 2019
As Doug Brake writes for Morning Consult, the new House majority has a unique opportunity to make good on a campaign promise and lock in permanent protections for net neutrality.
January 14, 2019
Congress should repeal and replace existing federal privacy laws with a common set of protections. We need comprehensive data privacy legislation that preempts state laws, improves transparency requirements, strengthens enforcement, and establishes a clear set of data privacy rights for Americans based on the sensitivity of the data and the context in which it is collected.
January 13, 2019
As David Hart writes for The Hill, it’s time to turn talk into action: Green New Dealers need to embrace all forms of clean energy, not just renewables, and congressional Republicans must accept that government has a positive role to play in reshaping energy markets.
January 7, 2019
A brief recap of some of the biggest developments and surprises in agricultural biotechnology innovation in 2018.
January 7, 2019
The next wave of digital innovation is coming. Countries can welcome it, prepare for it, and ride it to new heights of innovation and prosperity, or they can ignore the changing tide and miss the wave.
December 31, 2018
Adopting an international drug reference pricing scheme would limit drug innovation—potentially leading to higher, not lower, health care costs in the future—while at the same time reducing U.S. biopharmaceutical industry competitiveness, meaning fewer jobs and exports.
December 28, 2018
In an op-ed for InsideSources, Daniel Castro and Michael McLaughlin explain how the rise of cashierless stores, enabled by facial recognition technology, may help reduce racial discrimination while shopping.